Coming soon
Thanks for your interest, it will be ready very soon!
BIOENGINEERING AND MEDTECH AGAINST CANCER
Official time of the event
Event time
HomeAgendaOrganizersSpeakersExpertsNetworkingMeetings 1to1DocumentsStart-ups and R&D Projects
You are using Internet Explorer. The video meetings are not possible with this browser. Please use an updated version of Chrome, Firefox or Safari.
BIOENGINEERING AND MEDTECH AGAINST CANCER
November 24th - 25th
Medicen Paris Region and Biocat have decided, in the context of the digital oncology short course, to launch a call for expression of interest for a pitch elevator session. The objective is to identify and federate international actors of the oncology field to pitch their innovations in front of renown experts. The presented project of this pitch elevator session will aim to highlight international progress in oncology using innovative technologies and promote an interdisciplinary approach.

12 projects will be selected and will pitch in front of experts and investors on Wednesday 25th of November.

▹More information: https://medicen.org/wp-content/uploads/2020/09/ToHealth-AMI_Track-Innovation-1.pdf.

▹Application: please visit "Call for expression of interest".
Download the event app to get all the information in your mobile
Play store App store
Stéphanie Descroix
Research Director
Centre de recherche de l'Institut Curie
Matthias Lütolf
Professor
Ecole polytechnique Fédérale de Lausane (EPFL)
Elias Campo
Researcher
IDIBAPS
Álvaro Urbano-Ispizua
Hematologist
Hospital Clinic Barcelone and IDIBAPS
Sonia Guedan
Researcher
IDIBAPS
Pere Roca-Cusachs
Researcher
IBEC - Institute for Bioengineering of Catalonia
Laura Machesky
Professor
Beatson Institute for Cancer Resaerch
Jochen Guck
Professor
Max Planck Institute
Samuel Sanchez
Professor
IBEC - Institute for Bioengineering of Catalonia
María José Alonso
Researcher
University of Santiago de Compostela
Jan Van Hest
Professor
Eindhoven University
Teresa Sanchis
Executive coordinator
Nanomed Spain
Luis Pareras
Founding partner
Invivo Capital Partners (SGEIC)
Jan-Willem Van de Loo
Senior Scientific Officer at European Commission
European Commission DG Research & Innovation
Daniela Onofri
European Project Manager
Medicen Paris
Núria Martí
Director of Innovation
Biocat
Joan Montero
Senior Researcher 
IBEC - Institute for Bioengineering of Catalonia
Julien Taieb
Professor of hepatogastroenterology Paris Descartes university /Hopital Europeen Georges Pompidou
Hopital Européen Georges Pompidou (AP-HP)
Östling Päivi
Researcher Department of Oncology-Pathology
Karolinska Institutet
Núria Montserrat
Professor
IBEC - Institute for Bioengineering of Catalonia
Jessica Leygues
CEO
Medicen Paris Region
Blandine Hirtz
International Affairs Manager
Medicen Paris Region
Albane Pariset
Citizen - Patient & HCP organization Officer EIT Health France
EIT Health
Yuna Blum
Research Scientist at the Tumor Identity Card Program
Ligue contre le cancer
Jérôme Chekroun
Deployment and Market Access Director, Europe
Sivan INNOVATION
Laurent Gillot
Communications Chair
AF3M - Association Française des Malades du Myélome Multiple
Jacqueline Dubow
Vice- President Patient Association CCM
CCM -Connaître et Combattre les Myélodysplasies
Morgane Decultieux
Key Account Manager
Wefight
Josep SAMITIER
Director of IBEC, Institute for Bioengineering of Catalonia
IBEC, Institute for Bioengineering of Catalonia
Maria De la Fuente Freire
Phd
Nano-Oncology and Translational Therapeutics Unit Health Research Institute of Santiago de Compostela (IDIS) Clinical University Hospital of Santiago de Compostela (CHUS
Laurent Jacqueroud
Amine Marouf
Amaury Martin
Philippe Monteyne
Diana Gonzalez
Nuno Viegas
In Vivo Capital - Tbc
Caixa Capital Risk - Tbc
Ysios Capital - Tbc
Ysios Capital - Tbc
Aurora TT - Tbc